Table 1.
Identified procainamide metabolites in human, CYP2D6-humanized, and wild-type mice.
Symbol | RT (min) | Observed m/z | Formula | Mass error (ppm) | Identity | Detected |
---|---|---|---|---|---|---|
I | 0.91 | 236.1765 | C13H21N3O[H+] | 0.8 | Procainamide | Human, hCYP2D6, wild-type |
II | 1.83 | 278.1891 | C15H23N3O2[H+] | 7.9 | N-Acetylprocainamide | Human, hCYP2D6, wild-type |
III | 1.41 | 250.1564 | C13H19N3O2[H+] | 3.2 | N-Acetyl-desethylprocainamide | Human, hCYP2D6, wild-type |
IV | 0.51 | 208.1452 | C11H17N3O[H+] | 0.9 | Desethylprocainamide | Human, hCYP2D6, wild-type |
Va | 1.35 | 252.1696 | C13H21N3O2[H+] | −6.3 | Procainamide N-oxide | Human, hCYP2D6, wild-type |
VI | 0.74 | 252.1715 | C13H21N3O2[H+] | 1.2 | Procainamide hydroxylamine | Human, hCYP2D6, wild-type |
VIIa | 1.78 | 294.1832 | C15H23N3O3[H+] | 4.7 | Procainamide hydroxylamine acetic ester | Human, hCYP2D6, wild-type |
VIIIa | 2.14 | 294.1804 | C15H23N3O3[H+] | −4.7 | N-Acetylprocainamide N-oxide | Human, hCYP2D6, wild-type |
IXa | 1.57 | 264.1703 | C14H21N3O2[H+] | −3.4 | N-Formylprocainamide | Human, hCYP2D6, wild-type |
Xa | 3.02 | 430.2238 | C19H31N3O8[H+] | 11.4 | Procainamide hydroxylamine hexuronide | Human |
XIa | 2.47 | 292.2035 | C16H25N3O2[H+] | 3.4 | N-Propionylprocainamide | Human |
XIIa | 1.22 | 308.1596 | C15H21N3O4[H+] | −4.5 | N-Oxalylprocainamide | Human, |
XIIIa | 2.65 | 306.2193 | C17H27N3O2[H+] | 3.6 | N-Butyrylprocainamide | Human, hCYP2D6, wild-type |
XIVa | 3.15 | 306.2181 | C17H27N3O2[H+] | −0.3 | N-Isobutryrylprocainamide | Human |
Novel metabolites identified in this study.